The sapitinib-induced reversal of MDR to paclitaxel and doxorubicin in SW620/Ad300 cancer cells could also result from a decrease in vitro in the number or density of ABCB1 transporter present in the cancer cell membrane. This evidence concerns the gene ABCB1 and cancer.